Humana Inc. Files 8-K for Regulation FD Disclosure

Ticker: HUM · Form: 8-K · Filed: 2024-10-02T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, regulation-fd

TL;DR

Humana dropped an 8-K for a Reg FD disclosure - check for news.

AI Summary

On October 2, 2024, Humana Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure, indicating that the company has made a public disclosure of material information. No specific financial transactions or material events beyond this disclosure are detailed in the provided excerpt.

Why It Matters

This filing signals that Humana Inc. has made a public disclosure of information, which is important for investors to stay informed about material company news.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not contain information about significant financial changes, legal issues, or operational disruptions.

Key Players & Entities

Humana Inc. (company) — Registrant
October 2, 2024 (date) — Date of Report
500 West Main Street Louisville, KY 40202 (address) — Principal executive offices
502 - 580-1000 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this Form 8-K filing by Humana Inc.?

The primary purpose of this Form 8-K filing is to report a Regulation FD Disclosure, indicating that Humana Inc. has made a public disclosure of material information.

On what date was this Form 8-K filed?

This Form 8-K was filed on October 2, 2024.

What is the principal executive office address for Humana Inc.?

The address of Humana Inc.'s principal executive offices is 500 West Main Street, Louisville, KY 40202.

What is Humana Inc.'s telephone number?

Humana Inc.'s telephone number is 502 - 580-1000.

What is the state of incorporation for Humana Inc.?

Humana Inc. is incorporated in Delaware.

From the Filing

0000049071-24-000045.txt : 20241002 0000049071-24-000045.hdr.sgml : 20241002 20241002063547 ACCESSION NUMBER: 0000049071-24-000045 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241002 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20241002 DATE AS OF CHANGE: 20241002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 241345172 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20241002.htm 8-K hum-20241002 0000049071 false 0000049071 2024-10-02 2024-10-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K                  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  October 2, 2024 (October 2, 2024) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 1-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street Louisville , KY 40202 (Address of principal executive offices, including zip code) 502 - 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01 Regulation FD Disclosure. Based on preliminary 2025 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare and Medicaid Services (CMS), which became available in CMS Plan Finder as of October 1, 2024, Humana Inc. (“the Company”) has approximately 1.6 million, or 25%, of its members currently enrolled in plans rated 4 stars and above for 2025, a reduction from 94% in 2024. A significant driver of these results was contract H5216 decreasing to a 3.5-star rating from a 4.5-star rating in 2024. H5216 contains approximately 45% of Humana’s MA membership, including greater than 90% of its employer group waiver